Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading?
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading?
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume -, Issue -, Pages 1-9
Publisher
Informa UK Limited
Online
2022-04-18
DOI
10.1080/14656566.2022.2066997
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinically Meaningful Benefit in Women with Hypoactive Sexual Desire Disorder Treated with Flibanserin
- (2022) James A. Simon et al. Sexual Medicine
- The Neurobiology of Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women
- (2021) James G. Pfaus et al. CNS SPECTRUMS
- Prolactin as a neuroendocrine clue in sexual function of women across the reproductive life cycle: an expert point of view
- (2021) Rossella E. Nappi et al. GYNECOLOGICAL ENDOCRINOLOGY
- The Patient Experience of Premenopausal Women Treated with Bremelanotide for Hypoactive Sexual Desire Disorder: RECONNECT Exit Study Results
- (2021) Patricia Koochaki et al. JOURNAL OF WOMENS HEALTH
- A survival of the fittest strategy for the selection of genotypes by which drug responders and non-responders can be predicted in small groups
- (2021) Daniël Höhle et al. PLoS One
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- (2021) Sharon J. Parish et al. Journal of Sexual Medicine
- A Prospective Single-Arm Study Evaluating the Effects of a Multimodal Physical Therapy Intervention on Psychosexual Outcomes in Women With Dyspareunia After Gynecologic Cancer
- (2021) Marie-Pierre Cyr et al. Journal of Sexual Medicine
- Vaginal laser therapy for genitourinary syndrome of menopause – systematic review
- (2021) Eduard Mension et al. MATURITAS
- How Relevant is the Systemic Oxytocin Concentration for Human Sexual Behavior? A Systematic Review
- (2021) Nicoletta Cera et al. Sexual Medicine
- The role of hormone therapy in urogenital health after menopause
- (2021) Rossella E. Nappi et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms
- (2021) Fiona G. Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Beneficial effects of natural products on female sexual dysfunction: A systematic review and meta-analysis
- (2021) Nahdiya Sha'ari et al. PHYTOMEDICINE
- Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder
- (2020) Danielle Mayer et al. ANNALS OF PHARMACOTHERAPY
- Pelvic floor muscle training: mechanisms of action for the improvement of genitourinary syndrome of menopause
- (2020) J. Mercier et al. CLIMACTERIC
- Female Hypoactive Sexual Desire Disorder: A Practical Guide to Causes, Clinical Diagnosis, and Treatment
- (2020) Sheryl A. Kingsberg et al. JOURNAL OF WOMENS HEALTH
- The effect of oxytocin vaginal gel on vaginal atrophy in postmenopausal women: a randomized controlled trial
- (2020) Ilnaz Zohrabi et al. BMC Womens Health
- Botulinum Toxin A as a Treatment for Provoked Vestibulodynia
- (2020) Philip Haraldson et al. OBSTETRICS AND GYNECOLOGY
- Multimodal physical therapy versus topical lidocaine for provoked vestibulodynia: a prospective, multicenter, randomized trial
- (2020) Mélanie Morin et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Premature ovarian insufficiency: an International Menopause Society White Paper
- (2020) N. Panay et al. CLIMACTERIC
- Moderators of Improvement From Mindfulness-Based vs Traditional Cognitive Behavioral Therapy for the Treatment of Provoked Vestibulodynia
- (2020) Lori A. Brotto et al. Journal of Sexual Medicine
- Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions—Part III
- (2019) Sharon J. Parish et al. Journal of Sexual Medicine
- What are the challenges in prescribing pharmacotherapy for female sexual dysfunctions?
- (2019) Rossella E. Nappi et al. EXPERT OPINION ON PHARMACOTHERAPY
- Treatment of Vulvodynia: Pharmacological and Non-Pharmacological Approaches
- (2019) Natalie O. Rosen et al. DRUGS
- Sexuality in premature ovarian insufficiency
- (2019) R. E. Nappi et al. CLIMACTERIC
- The International Society for the Study of Women's Sexual Health Process of Care for the Identification of Sexual Concerns and Problems in Women
- (2019) Sharon J. Parish et al. MAYO CLINIC PROCEEDINGS
- Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data
- (2019) Rakibul M Islam et al. Lancet Diabetes & Endocrinology
- Testosterone for women: green light for sex, amber light for health?
- (2019) Rossella E Nappi Lancet Diabetes & Endocrinology
- Global Consensus Position Statement on the Use of Testosterone Therapy for Women
- (2019) Susan R. Davis et al. CLIMACTERIC
- Bremelanotide: First Approval
- (2019) Sohita Dhillon et al. DRUGS
- Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide
- (2019) Stanley Althof et al. Journal of Sexual Medicine
- Effects of Timing of Flibanserin Administration Relative to Alcohol Intake in Healthy Premenopausal Women: A Randomized, Double-Blind, Crossover Study
- (2019) James A. Simon et al. Journal of Sexual Medicine
- Safety and Tolerability of Evening Ethanol Consumption and Bedtime Administration of Flibanserin in Healthy Premenopausal Female Subjects
- (2019) Leah Millheiser et al. Sexual Medicine
- Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women
- (2019) Rossella E. Nappi et al. Frontiers in Endocrinology
- Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder
- (2019) Sheryl A. Kingsberg et al. OBSTETRICS AND GYNECOLOGY
- Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder
- (2019) James A. Simon et al. OBSTETRICS AND GYNECOLOGY
- Evaluation of safety for flibanserin
- (2019) Anita H Clayton et al. Expert Opinion On Drug Safety
- Dose-Finding Study of Lorexys for Hypoactive Sexual Desire Disorder in Premenopausal Women
- (2019) Robert E. Pyke et al. Journal of Sexual Medicine
- Effects of Alcohol Administered With Flibanserin in Healthy Premenopausal Women: A Randomized, Double-Blind, Single-Dose Crossover Study
- (2019) James A. Simon et al. Journal of Sexual Medicine
- Sexual well-being after menopause: An International Menopause Society White Paper
- (2018) J. A. Simon et al. CLIMACTERIC
- Has flibanserin revolutionized the treatment of hypoactive sexual desire disorder or is there still room for more effective therapeutics?
- (2018) Rossella E. Nappi et al. EXPERT OPINION ON PHARMACOTHERAPY
- The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women
- (2018) Anita H. Clayton et al. MAYO CLINIC PROCEEDINGS
- Female Sexual Dysfunction and the Placebo Effect
- (2018) James M. Weinberger et al. OBSTETRICS AND GYNECOLOGY
- Evaluation and Management of Hypoactive Sexual Desire Disorder
- (2018) Anita H. Clayton et al. Sexual Medicine
- Expert opinion on existing and developing drugs to treat female sexual dysfunction
- (2018) Melanie K. Miller et al. EXPERT OPINION ON EMERGING DRUGS
- Best Practices in North American Pre-Clinical Medical Education in Sexual History Taking: Consensus From the Summits in Medical Education in Sexual Health
- (2018) Elizabeth S. Rubin et al. Journal of Sexual Medicine
- Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis
- (2017) Chiara Achilli et al. FERTILITY AND STERILITY
- BP101 Peptide Promotes Female Sexual Receptivity in the Rat
- (2017) Alexander Andreev-Andrievskiy et al. Journal of Sexual Medicine
- Understanding the Role of Serotonin in Female Hypoactive Sexual Desire Disorder and Treatment Options
- (2017) Harry A. Croft Journal of Sexual Medicine
- Hypoactive Sexual Desire Disorder
- (2017) Irwin Goldstein et al. MAYO CLINIC PROCEEDINGS
- The Oxytocin–Vasopressin Pathway in the Context of Love and Fear
- (2017) C. Sue Carter Frontiers in Endocrinology
- 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
- (2016) R. J. Baber et al. CLIMACTERIC
- Future Targets for Female Sexual Dysfunction
- (2016) Melissa Farmer et al. Journal of Sexual Medicine
- The Physiology of Female Sexual Function and the Pathophysiology of Female Sexual Dysfunction (Committee 13A)
- (2016) Roy J. Levin et al. Journal of Sexual Medicine
- Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions—Part I
- (2016) Leonard R. Derogatis et al. Journal of Sexual Medicine
- Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions—Part II
- (2016) Sharon J. Parish et al. Journal of Sexual Medicine
- Risk Factors for Sexual Dysfunction Among Women and Men: A Consensus Statement From the Fourth International Consultation on Sexual Medicine 2015
- (2016) Marita P. McCabe et al. Journal of Sexual Medicine
- Psychological and Interpersonal Dimensions of Sexual Function and Dysfunction
- (2016) Lori Brotto et al. Journal of Sexual Medicine
- Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL)
- (2016) Prof. Rossella E. Nappi et al. MATURITAS
- FDA Approval of Flibanserin — Treating Hypoactive Sexual Desire Disorder
- (2016) Hylton V. Joffe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women
- (2016) Loes Jaspers et al. JAMA Internal Medicine
- Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women
- (2015) Ida Dhanuka et al. EXPERT OPINION ON PHARMACOTHERAPY
- Why are there no FDA-approved treatments for female sexual dysfunction?
- (2015) Rossella E Nappi EXPERT OPINION ON PHARMACOTHERAPY
- Advances in pharmacotherapy for treating female sexual dysfunction
- (2015) Rossella E Nappi et al. EXPERT OPINION ON PHARMACOTHERAPY
- Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial
- (2015) Dana A. Muin et al. FERTILITY AND STERILITY
- Improving prospects for treating hypoactive sexual desire disorder (HSDD): development status of flibanserin
- (2014) J Thorp et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Sexual dysfunction associated with major depressive disorder and antidepressant treatment
- (2014) Anita H Clayton et al. Expert Opinion On Drug Safety
- Drugs in early clinical development for the treatment of female sexual dysfunction
- (2014) Zoe R Belkin et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Differential effects of intranasal oxytocin on sexual experiences and partner interactions in couples
- (2014) Behnoush Behnia et al. HORMONES AND BEHAVIOR
- Testosterone Improves Antidepressant‐Emergent Loss of Libido in Women: Findings from a Randomized, Double‐Blind, Placebo‐Controlled Trial
- (2014) Ensieh Fooladi et al. Journal of Sexual Medicine
- Pharmacogenomics and sexuality: a vision
- (2013) R. E. Nappi et al. CLIMACTERIC
- Sexual Health Issues in Women with Cancer
- (2013) Michael Krychman et al. Journal of Sexual Medicine
- Efficacy of Flibanserin in Women with Hypoactive Sexual Desire Disorder: Results from the BEGONIA Trial
- (2013) Molly Katz et al. Journal of Sexual Medicine
- Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder
- (2013) James A. Simon et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Efficacy and Safety of Testosterone in the Management of Hypoactive Sexual Desire Disorder in Postmenopausal Women
- (2012) Susan R. Davis et al. Journal of Sexual Medicine
- Influence of Sildenafil on Genital Engorgement in Women with Female Sexual Arousal Disorder
- (2012) Laura S. Leddy et al. Journal of Sexual Medicine
- Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women: Efficacy of Flibanserin in the VIOLET Study
- (2012) Leonard R. DeRogatis et al. Journal of Sexual Medicine
- Open‐Label Extension Study of Flibanserin in Women with Hypoactive Sexual Desire Disorder
- (2012) Christopher Jayne et al. Journal of Sexual Medicine
- Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women: Efficacy of Flibanserin in the DAISY Study
- (2012) John Thorp et al. Journal of Sexual Medicine
- Flibanserin: Initial Evidence of Efficacy on Sexual Dysfunction, in Patients with Major Depressive Disorder
- (2010) Sidney Kennedy Journal of Sexual Medicine
- Sexual Problems and Distress in United States Women
- (2010) Jan L. Shifren et al. OBSTETRICS AND GYNECOLOGY
- Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women
- (2009) Kristen B. Levine et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Sildenafil citrate for female sexual arousal disorder: a future possibility?
- (2009) Corina Schoen et al. Nature Reviews Urology
- RETRACTED: Evaluation of the Safety and Efficacy of Bremelanotide, a Melanocortin Receptor Agonist, in Female Subjects with Arousal Disorder: A Double-Blind Placebo-Controlled, Fixed Dose, Randomized Study
- (2008) Mohammad Reza Safarinejad Journal of Sexual Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now